Inventory increased 43.4%
Inventory changed +43.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +43.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +2477 basis points from the comparable as-filed period.
Cash & equivalents changed +49.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +122.6% from the comparable as-filed period.
Gross profit changed +128.1% from the comparable as-filed period.
Inventory / revenue changed -3794 basis points from the comparable as-filed period.
Operating income changed +1220.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Gross margin changed +115 basis points from the comparable as-filed period.
SBC / revenue changed -265 basis points from the comparable as-filed period.
Research & development changed +22.9% from the comparable as-filed period.
Net income changed +1845.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Selling, general & administrative changed +15.6% from the comparable as-filed period.
Stock-based compensation changed -0.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.